Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.63 |
| ▸ | MAPT | P10636 | 7/20 | 0.63 |
| ▸ | NPC1 | O15118 | 6/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.63 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.63 |
| ▸ | RELA | Q04206 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | APP | P05067 | 4/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26536350 | 1.00 | RAB9A (0.63) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL21891101 | 0.97 | RAB9A (0.67) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL26536355 | 0.91 | RAB9A (0.60) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL24155737 | 0.89 | RAB9A (0.61) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL12376182 | 0.89 | RAB9A (0.73) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL5461064 | 0.88 | RAB9A (0.77) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL22524395 | 0.87 | RAB9A (0.71) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL24557199 | 0.87 | KDM4E (0.59) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL28501886 | 0.84 | RAB9A (0.50) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 | |
| SCHEMBL17701240 | 0.83 | RAB9A (0.67) | RAB9AKDM4EMAPTNPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230322691-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CCNT1, CCNE2, SCO2 | RAB9A 3962/4885KDM4E 3380/4885MAPT 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.